Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc. (NASDAQ: AMED) is a leading healthcare services company in the United States, specializing in delivering personalized home health, hospice, and high-acuity care services. Headquartered in Baton Rouge, LA, with an executive office in Nashville, TN, the company employs around 18,700 staff across 520 care centers in 37 states and the District of Columbia. Founded in 1982, Amedisys is dedicated to providing quality, clinically-distinctive care to more than 469,000 patients annually, with over 10.6 million visits each year.
Amedisys operates across four key segments: Home Health, Hospice, High Acuity Care, and Personal Care. The Home Health segment offers skilled nursing, therapy, and aid services directly in patients' homes, while the Hospice segment provides end-of-life care to terminally ill patients. The High Acuity Care segment delivers critical inpatient care elements at home, and the Personal Care segment, which was divested in March 2023, offered assistance with daily living activities.
Amedisys's commitment to high-quality care is underpinned by its comprehensive coordination with healthcare providers and personalized care plans tailored to each patient's unique needs. With a strong network involving more than 3,000 hospitals and 110,000 physicians nationwide, Amedisys is a trusted partner in post-acute care.
Recent notable achievements include a merger agreement with UnitedHealth Group, aimed at enhancing patient care through integrated services. Financially, Amedisys reported a net service revenue increase to $571.4 million for Q1 2024, reflecting a robust service demand despite divesting the Personal Care segment.
Additionally, Amedisys is actively involved in advancing healthcare technology. The company has partnered with Patient Choice Laboratories to incorporate advanced molecular testing, enhancing infection diagnosis and patient outcomes. This innovation underscores Amedisys’s commitment to leveraging cutting-edge technology to improve patient care.
For stakeholders, Amedisys remains a prominent figure in the home healthcare industry, constantly adapting and growing to meet the increasing needs of its patient population. The company's strategic partnerships and advancements in healthcare technology position it well for sustained growth and improved patient outcomes.
Amedisys, Inc. (NASDAQ: AMED) announced that CEO Paul B. Kusserow will present at the Jefferies Virtual London Healthcare Conference on November 17, 2020, starting at 9:25 a.m. Eastern Time. The presentation will be accessible via live webcast on Amedisys' investor relations website. Amedisys is a leading provider of home health, hospice, and personal care services, serving over 415,000 patients annually through 516 care centers across 39 states and D.C. The company is committed to delivering high-quality healthcare at home.
Amedisys, a leader in home health, hospice, and personal care, announces that CEO Paul B. Kusserow will present at the Stephens Annual Investment Conference on November 19, 2020, at 2:00 p.m. ET. Investors can access the live webcast via the Amedisys website. Founded in 1982 and headquartered in Baton Rouge, LA, Amedisys operates over 500 care centers across 39 states and serves more than 415,000 patients annually, partnering with over 2,600 hospitals and 67,000 physicians nationwide.
Amedisys, Inc. (NASDAQ: AMED), a top provider of home health, hospice, and personal care services, announced that CEO Paul B. Kusserow will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on November 10, 2020, at 2:00 p.m. Eastern Time. The presentation will be available via live webcast on the Amedisys website. Established in 1982 and headquartered in Baton Rouge, LA, Amedisys serves over 415,000 patients annually through its 516 care centers across 39 states and the District of Columbia, employing 21,000 staff dedicated to quality care.
Amedisys, Inc. (NASDAQ: AMED) reported significant growth for Q3 2020, with net service revenue increasing by $49.5 million to $544.1 million compared to Q3 2019. Net income rose to $72.0 million ($2.16 per diluted share), aided by a $0.72 income tax benefit. Year-to-date results also showed a revenue increase of $65.9 million, totaling $1.520 billion, and net income of $138.5 million ($4.16 per diluted share). The company raised its full-year revenue guidance to $2.067-$2.072 billion and adjusted EBITDA forecast to $269-$272 million, asserting strong performance despite COVID-19 challenges.
Amedisys, Inc. (NASDAQ: AMED) will disclose its third-quarter financial results on October 28, 2020, after the market closes. An investor conference call is scheduled for October 29, 2020, at 11:00 a.m. ET to discuss these results. Interested participants can join by calling (877) 524-8416 (Toll-Free) or (412) 902-1028 (Toll). A replay will be available until November 29, 2020. Amedisys offers personalized home health care and hospice services, serving over 415,000 patients annually through more than 21,000 employees across 39 states.
Amedisys, a leading home health, hospice, and personal care company, will have its CEO, Paul B. Kusserow, present at the Baird 2020 Global Healthcare Conference on September 10, 2020, at 1:25 p.m. Eastern Time. Investors can access a live webcast of the presentation through the Amedisys investor relations website. Amedisys, founded in 1982 and headquartered in Baton Rouge, LA, provides personalized care to over 415,000 patients annually through its extensive network of 524 care centers across 39 states.
Amedisys, Inc. (NASDAQ: AMED) announced a Care Coordination Agreement with BrightStar Care, integrating their personal care agencies into the Amedisys Personal Care Network. This partnership aims to enhance care coordination between Amedisys' hospice and home health centers, reaching approximately 75% of the U.S. population through BrightStar's 340 locations across 38 states. The pilot program will start in Pennsylvania and Texas, focusing on reducing hospital admissions by effectively managing patients with chronic conditions.
Amedisys, Inc. (NASDAQ: AMED) reported Q2 2020 net service revenue of $485 million, down $8 million from $493 million in 2019. Net income increased to $34.7 million ($1.04 per diluted share) from $33.7 million ($1.02) year-over-year. Year-to-date revenue rose to $976.7 million, with net income of $66.5 million ($2.00 per diluted share), up from $65 million ($1.98). The company reaffirmed its 2020 guidance, anticipating annual net revenue between $2.040 billion and $2.070 billion and adjusted EBITDA of $245 million to $255 million. CEO Paul B. Kusserow highlighted company resilience during the COVID-19 pandemic.
Amedisys, Inc. (NASDAQ: AMED) will report its Q2 results for the period ending June 30, 2020, after market close on July 28, 2020. An investor conference call will be held the next day, July 29, 2020, at 11:00 a.m. ET to discuss these results. Participants can join via telephone or listen to a live webcast on the company’s Investor Relations page. Amedisys is a leader in healthcare at home, offering personalized home health, hospice, and personal care to over 415,000 patients annually, with a workforce of 21,000 across 526 care centers in 39 states.
Amedisys, Inc. (NASDAQ: AMED) announced that its President and CEO, Paul B. Kusserow, will present at the 2020 BMO Prescriptions for Success Healthcare Conference on June 23, 2020, at 1:00 p.m. Eastern Time. Amedisys, a leading home health, hospice, and personal care company, emphasizes personalized care and has partnerships with over 2,600 hospitals and 67,000 physicians. The company serves more than 415,000 patients annually across 39 states and the District of Columbia, employing 22,000 staff in 524 care centers.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
What services does Amedisys Inc. provide?
Where is Amedisys Inc. headquartered?
How many employees does Amedisys have?
What is the scope of Amedisys's operations?
How many patients does Amedisys serve annually?
What recent merger has Amedisys entered into?
What recent technological advancement has Amedisys incorporated?
What was Amedisys's net service revenue for Q1 2024?
How does Amedisys coordinate patient care?
What was the Personal Care segment of Amedisys?
